Abstract
Differences between children and adults have both technical and ethical implications for the design, interpretation and employment of economic analyses of health-related programmes. Even though policy makers increasingly turn to economic analyses to inform decisions about resource allocation, pertinent child-adult differences have received fragmented discussion in leading methodological references.
Key areas warranting attention include: the ways in which a child’s distinctive biology modifies the cost and effectiveness of healthcare interventions; challenges in assessing utilities for infants and young children given their limited but developing cognitive capacity; how a child’s age, dependency and disability affect the selection of the appropriate time horizon and scope of the analysis; whether a child’s non-wage earning productivity should be incorporated into analyses, and if so, what metric to use; what principles of equity policy makers should employ in using economic evaluations to choose between child- and adult-focused interventions; and whether special protective measures should be introduced to secure the rights and interests of children who cannot advocate for themselves.
Similar content being viewed by others
References
Halpern SA. American pediatrics: the social dynamics of professionalism, 1880–1980. Berkeley (CA): University California Press, 1988
Stern AM, Markel H. Formative years: children’s health in the United States: 1880–2000. Ann Arbor (MI): University of Michigan Press, 2002
Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996
Graham JD, Goldie SJ, Segui-Gomez M, et al. Reducing risks to children in vehicles with passenger airbags. Pediatrics 1998; 102: e3
Graham JD, Thompson KM, Goldie SJ, et al. The cost-effectiveness of air bags by seating position. JAMA 1997; 278: 1418–25
Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation [comment]. New Engl J Med 1992; 327: 1832–5
Milunsky A, Jick H, Jick SS, et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects [comment]. JAMA 1989; 262: 2847–52
Wald DS, Law M, Moms JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 2002;325:1202
Romano PS, Waitzman NJ, Scheffler RM, et al. Folic acid fortification of grain: an economic analysis. Am J Public Health 1995; 85: 667–76
Jenney ME, Campbell S. Measuring quality of life. Arch Dis Child 1997; 77: 347–50
Juniper EF, Guyatt GH, Feeny DH, et al. Minimum skills required by children to complete health-related quality of life instruments for asthma: comparison of measurement properties. Fur Respir l 1997; 10: 2285–94
Guyatt GH, Juniper EF, Griffith LE, et al. Children and adult perceptions of childhood asthma. Pediatrics 1997; 99: 165–8
Yi MS, Britto MT, Wilmott RW, et al. Health values of adolescents with cystic fibrosis. J Pediatr 2003; 142: 133–40
Saigal S, Stoskopf BL, Feeny D, et al. Differences in preferences for neonatal outcomes among health care professionals, parents, and adolescents. JAMA 1999; 281: 1991–7
Torrance GW, Furlong W, Feeny D, et al. Multi-attribute preference functions: Health Utilities Index. Pharmacoeconomics 1995; 7 (6: 503–20
Feeny D, Furlong W, Boyle M, et al. Multi-attribute health status classification systems: Health Utilities Index. Pharmacoeconomics 1995; 7 (6: 490–502
EuroQol: a new facility for the measurement of health-related quality of life: The EuroQol Group. Health Policy 1990; 16: 199–208
Stolk EA, Busschbach JJ, Vogels T. Performance of the EuroQol in children with imperforate anus. Qual Life Res 2000; 9: 29–38
Kaplan RM, Anderson JP. A general health policy model: update and applications. Health Serv Res 1988; 23: 203–35
Lieu TA, Cochi SL, Black SB, et al. Cost-effectiveness of a routine varicella vaccination program for US children. JAMA 1994; 271: 375–81
Keren R, Helfand M, Homer C, et al. Projected cost-effectiveness of statewide universal newborn hearing screening. Pediatrics 2002; 110: 855–64
Barringer D, Mauk G. Survey of parents perceptions regarding hospital-based newborn hearing screening. Audiology Today 1997; 9: 18–9
Clemens CJ, Davis SA, Bailey AR. The false-positive in universal newborn hearing screening. Pediatrics 2000; 106: E7
Margolis HS, Coleman PJ, Brown RE, et al. Prevention of hepatitis B virus transmission by immunization: an economic analysis of current recommendations. JAMA 1995; 274: 1201–8
Pedersen S, Warner J, Wahn U, et al. Growth, systemic safety, and efficacy during 1 year of asthma treatment with different beclomethasone dipropionate formulations: an open-label, ran domized comparison of extrafine and conventional aerosols in children. Pediatrics 2002; 109: e92
Allen DB. Inhaled corticosteroid therapy for asthma in preschool children: growth issues. Pediatrics 2002; 109: 373–80
de Benedictis FM, Teper A, Green RJ, et al. Effects of 2 inhaled corticosteroids on growth: results of a randomized controlled trial. Arch Pediatr Adolesc Med 2001; 155: 1248–54
Harris J. QALYfying the value of life. J Med Ethics 1987; 13: 117–23
Singer P, McKie J, Kuhse H, et al. Double jeopardy and the use of QALYs in health care allocation. J Med Ethics 1995; 21: 144–50
Cretin S. Cost/benefit analysis of treatment and prevention of myocardial infarction. Health Serv Res 1977; 12: 174–89
Boyle MIL Torrance GW, Sinclair JC, et al. Economic evaluation of neonatal intensive care of very-low-birth-weight infants. N Engl J Med 1983; 308: 1330–7
Williams A. Intergenerational equity: an exploration of the ‘fair innings’ argument. Health Econ 1997; 6: 117–32
Patrick DL, Erickson P. Health status and health policy: quality of life in health care evaluation and resources allocation. New York: Oxford University Press, 1993
Proctor BD, Dalaker J. Poverty in the United States: 2001: current population reports. Washington, DC: Census Bureau, 2002: P60–219
Benjamin AE, Newacheck PW, Wolfe H. Intergenerational equity and public spending. Pediatrics 1991; 88: 75–83
Detsky AS, Naglie IG. A clinician’s guide to cost-effectiveness analysis. Ann Intern Med 1990; 113: 147–54
Ubel PA, DeKay ML, Baron J, et al. Cost-effectiveness analysis in a setting of budget constraints: is it equitable? N Engl J Med 1996; 334: 1174–7
Ubel PA, Baron J, Nash B, et al. Are preferences for equity over efficiency in health care allocation all or nothing’? Med Care 2000; 38: 366–73
Ubel PA, Baron J, Asch DA. Preference for equity as a framing effect. Med Decis Making 2001; 21: 180–9
Acknowledgements
We thank David Asch, Tracy Lieu, David Mandell, and Louise Warren for their help and thoughtful comments.
Dr Feudtner was supported by grant number K08 HS00002 from the Agency for Healthcare Research and Quality.
Dr. Keren was supported by grant number K23 HD043179 from the National Institute of Child Health and Human Development, Bethesda, MD.
The authors have no conflicts of interest that are directly relevant to the contents of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Keren, R., Pati, S. & Feudtner, C. The Generation Gap. PharmacoEconomics 22, 71–81 (2004). https://doi.org/10.2165/00019053-200422020-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00019053-200422020-00001